J. Gerry Kenna
0000-0002-6927-8962
Publication & Citation Trends
Publications
0 total
Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats OA
Cited by 5
Semantic Scholar
Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessment. OA
Cited by 21
Semantic Scholar
Editorial: Advances in alternative methods in preclinical pharmacology and toxicology OA
Cited by 1
Semantic Scholar
Advancing nonclinical innovation and safety in pharmaceutical testing. OA
Cited by 11
Semantic Scholar
Safety Assessment of Pharmaceuticals
Cited by 1
Semantic Scholar
Noninvasive Preclinical and Clinical Imaging of Liver Transporter Function Relevant to Drug-Induced Liver Injury
Cited by 7
Semantic Scholar
Interpretation, Integration, and Implementation of In Vitro Assay Data: The Predictive Toxicity Challenge
Cited by 6
Semantic Scholar
Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
Cited by 26
Semantic Scholar
Research Topics
Drug-Induced Hepatotoxicity and Protection
(57)
Pharmacogenetics and Drug Metabolism
(48)
Drug Transport and Resistance Mechanisms
(36)
Liver Disease Diagnosis and Treatment
(15)
Computational Drug Discovery Methods
(10)
Affiliations
AstraZeneca (United Kingdom)
Oslo University Hospital
National Institutes of Health
Nottingham University Hospitals NHS Trust
University of Nottingham